257 related articles for article (PubMed ID: 9021926)
1. CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cells.
Pericle F; Epling-Burnette PK; Podack ER; Wei S; Djeu JY
J Leukoc Biol; 1997 Feb; 61(2):201-8. PubMed ID: 9021926
[TBL] [Abstract][Full Text] [Related]
2. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
[TBL] [Abstract][Full Text] [Related]
3. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
6. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
7. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
9. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
Kalinichenko TV; Mokyr MB
Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
[TBL] [Abstract][Full Text] [Related]
10. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
11. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
[No Abstract] [Full Text] [Related]
13. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
15. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
18. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
19. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
